Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 25% ± 11% | |
lung | 8 studies | 32% ± 13% | |
intestine | 8 studies | 25% ± 11% | |
bone marrow | 5 studies | 27% ± 10% | |
liver | 5 studies | 31% ± 22% | |
placenta | 4 studies | 36% ± 20% | |
prostate | 4 studies | 53% ± 25% | |
lymph node | 4 studies | 26% ± 5% | |
eye | 3 studies | 27% ± 8% | |
breast | 3 studies | 29% ± 10% | |
skin | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 21278.25 | 1808 / 1809 | 98% | 669.55 | 464 / 472 |
lung | 96% | 3960.31 | 553 / 578 | 95% | 531.56 | 1100 / 1155 |
stomach | 86% | 4331.30 | 307 / 359 | 99% | 702.35 | 282 / 286 |
thymus | 97% | 2902.63 | 636 / 653 | 80% | 215.14 | 484 / 605 |
breast | 84% | 2321.66 | 387 / 459 | 83% | 209.16 | 928 / 1118 |
intestine | 68% | 3527.61 | 659 / 966 | 99% | 776.41 | 522 / 527 |
bladder | 62% | 2151.57 | 13 / 21 | 96% | 566.17 | 486 / 504 |
pancreas | 62% | 1179.82 | 204 / 328 | 91% | 409.03 | 162 / 178 |
esophagus | 48% | 7642.59 | 687 / 1445 | 100% | 753.99 | 183 / 183 |
brain | 87% | 2810.64 | 2296 / 2642 | 48% | 94.89 | 339 / 705 |
uterus | 28% | 819.82 | 47 / 170 | 94% | 529.55 | 433 / 459 |
ovary | 2% | 23.52 | 3 / 180 | 100% | 837.62 | 428 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 726.36 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1079.61 | 29 / 29 |
spleen | 100% | 5765.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 529.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 514.52 | 1 / 1 |
kidney | 81% | 3982.73 | 72 / 89 | 19% | 48.37 | 172 / 901 |
muscle | 99% | 5906.70 | 796 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 11335.17 | 899 / 929 | 0% | 0 | 0 / 0 |
prostate | 82% | 2307.30 | 200 / 245 | 13% | 15.69 | 67 / 502 |
adipose | 72% | 1990.53 | 871 / 1204 | 0% | 0 | 0 / 0 |
heart | 70% | 1573.97 | 606 / 861 | 0% | 0 | 0 / 0 |
liver | 14% | 414.03 | 32 / 226 | 44% | 109.67 | 177 / 406 |
adrenal gland | 11% | 222.88 | 29 / 258 | 33% | 54.34 | 77 / 230 |
blood vessel | 20% | 433.03 | 271 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0090402 | Biological process | oncogene-induced cell senescence |
GO_0006268 | Biological process | DNA unwinding involved in DNA replication |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006337 | Biological process | nucleosome disassembly |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035985 | Cellular component | senescence-associated heterochromatin focus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140677 | Molecular function | molecular function activator activity |
GO_0008301 | Molecular function | DNA binding, bending |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0030527 | Molecular function | structural constituent of chromatin |
GO_0046965 | Molecular function | nuclear retinoid X receptor binding |
GO_0042974 | Molecular function | nuclear retinoic acid receptor binding |
GO_0003680 | Molecular function | minor groove of adenine-thymine-rich DNA binding |
GO_0042975 | Molecular function | peroxisome proliferator activated receptor binding |
GO_0003723 | Molecular function | RNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HMGA1 |
Protein name | High mobility group protein HMG-I/HMG-Y (High mobility group AT-hook protein 1) High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R) High mobility group AT-hook 1 |
Synonyms | HMGIY |
Description | FUNCTION: HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double-stranded DNA. It is suggested that these proteins could function in nucleosome phasing and in the 3'-end processing of mRNA transcripts. They are also involved in the transcription regulation of genes containing, or in close proximity to A+T-rich regions. FUNCTION: HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double-stranded DNA. It is suggested that these proteins could function in nucleosome phasing and in the 3'-end processing of mRNA transcripts. They are also involved in the transcription regulation of genes containing, or in close proximity to A+T-rich regions. . FUNCTION: HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double-stranded DNA. It is suggested that these proteins could function in nucleosome phasing and in the 3'-end processing of mRNA transcripts. They are also involved in the transcription regulation of genes containing, or in close proximity to A+T-rich regions. . FUNCTION: HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double-stranded DNA. It is suggested that these proteins could function in nucleosome phasing and in the 3'-end processing of mRNA transcripts. They are also involved in the transcription regulation of genes containing, or in close proximity to A+T-rich regions. . FUNCTION: HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double-stranded DNA. It is suggested that these proteins could function in nucleosome phasing and in the 3'-end processing of mRNA transcripts. They are also involved in the transcription regulation of genes containing, or in close proximity to A+T-rich regions. . |
Accessions | ENST00000703808.1 ENST00000374116.3 [P17096-2] Q6IPL9 A0A994J705 ENST00000703809.1 ENST00000674029.1 P17096 ENST00000347617.10 [P17096-2] A0A994J434 ENST00000311487.9 [P17096-1] Q5T6U8 ENST00000447654.5 [P17096-1] A0A669KAX1 ENST00000401473.7 [P17096-2] |